GPR75 protein may be fatty liver disease therapeutic target: Study
Reduced activity of a protein called GPR75 appears to help prevent the buildup of fat in the liver and the subsequent development of metabolic dysfunction-associated…
Fatty liver disease is a term used to refer to a group of disorders characterized by abnormal amounts of fat in the liver. Together, these diseases are estimated to affect more than one-third of people in the U.S. and other industrialized countries.
Read moreFatty liver disease treatment approaches will depend on the condition’s exact cause. But patients are generally encouraged to make lifestyle changes, such as diet and exercise, that aim to promote weight loss and reduce the amount of fat in the body.
Read moreReduced activity of a protein called GPR75 appears to help prevent the buildup of fat in the liver and the subsequent development of metabolic dysfunction-associated…
The U.S. government soon will launch a first national study to assess the prevalence of metabolic dysfunction-associated steatotic liver disease, or MASLD — a liver…